Business Wire14d
Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System
--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius ... With Vision 2026, as part of the #FutureFresenius strategy, the company is developing, producing, and selling new products ...
Business Insider27d
EQS-News: Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara®
Fresenius Kabi puts essential medicines and technologies in the hands of people who help patients and finds the best answers to the challenges they face. Following its strategy “Vision 2026 ...
pharmaphorum2d
EU has its first RoActemra biosimilar, from Fresenius Kabi
The European Commission has approved the first biosimilar version of Actemra/RoActemra, Roche’s $3 billion blockbuster, from German drugmaker Fresenius Kabi. The biosimilar of IL-6 inhibitor ...
Business Wire1mon
U.S. Compounding Pharmacy Market Industry Outlook & Forecast 2024-2029, Featuring Profiles for Avella Specialty Pharmacy, CAPS, Fagron, Fresenius Kabi and PenCol Pharmacy ...
DUBLIN--(BUSINESS WIRE)--The "U.S. Compounding Pharmacy ... market are Avella Specialty Pharmacy, CAPS, Fagron, Fresenius Kabi, and PenCol Pharmacy. Avella Specialty Pharmacy, a prominent player ...
Joplin Globe13d
Fresenius Kabi Receives FDA 510(k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora Xi Plasmapheresis System
Fresenius Kabi Receives FDA 510 (k) Clearance for Adaptive Nomogram, Enhancing Plasma Collection Efficiency with the Aurora ...